A new biomarker function for a long-known hormone
Plasma adiponectin is a potential biomarker for organ involvement in male Fabry disease patients
Adiponectin is a hormone with well-known relevance to cardiac and renal function. As Fabry disease (FD), a rare metabolic disorder, often manifests with cardiac and/or renal symptoms, researchers at CENTOGENE examined a potential link to adiponectin. Their finding of plasma adiponectin levels to correlate with heart and kidney damage in FD patients were published in the journal Blood Cells, Molecules, and Diseases.